Keywords: nexmed, befar, safe, phase, iii, alprostadil, topical

Nexmed's Befar Safe In Phase III

Article | 03 December 1998

Print This

Nexmed's Befar (alprostadil topical cream) was proven safe andeffective in a Phase III trial in China. The company will produce ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in